Managing cancer outpatients during the pandemic: Tips from MSKCCFebruary 8, 2021Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanomaOncology
COVID-19 vaccination in cancer patients: NCCN outlines prioritiesFebruary 1, 2021Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggestNovember 25, 2020Genitourinary CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaOncologyLung Cancer
Neoadjuvant immunotherapy combo produces high response rate in melanomaNovember 25, 2020MelanomaOncology
Low threshold to biopsy atypical lesions may ID vulvar melanoma early, experts sayNovember 16, 2020MelanomaOncology
Real-world results with checkpoint inhibitors found inferior to trial resultsOctober 30, 2020Lung CancerMelanomaHead & Neck/Thyroid CancersGenitourinary Cancer
Lower BP and better tumor control with drug combo?October 26, 2020Lung CancerBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell DisordersMelanoma
The scope of under- and overtreatment in older adults with cancerOctober 1, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020Breast CancerLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerMelanomaLymphoma & Plasma Cell Disorders
COVID-19 prompts ‘democratization’ of cancer trialsSeptember 16, 2020Genitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanomaOncology
